Results 31 to 40 of about 2,062 (180)

TEDARİK ZİNCİRİ KOORDİNASYONU VE YENİLİKÇİLİK: SOSYAL ETKİLENME VE ÖĞRENME YAKLAŞIMI

open access: yesKAÜ-İİBF Dergisi, 2020
Günümüzde hızla değişen piyasa koşullarına ayak uydurabilmek ve piyasada uzun vadede rekabet avantajı sağlayabilmek adına işletmelerin yenilikçilik anlayışını benimsemesi önemli bir faktör olarak karşımıza çıkmaktadır. Birçok büyük şirketin rekabetle baş
Gülşah Korkmaz, Dilşad Güzel
doaj   +1 more source

Hayat Dışı Sigorta Şirketlerinin Finansal Performans Analizinde Topsis ve Mabac Yöntemlerinin Değerlendirilmesi

open access: yesİzmir İktisat Dergisi, 2022
Performans değerlendirmesi, tüm sektörlerde olduğu gibi sigorta sektöründe faaliyet gösteren şirketlerin de hedeflerinin değerlendirilmesini esas almaktadır.
Gülay Çizgici Akyüz
doaj   +1 more source

Return to performance criteria in soccer after musculoskeletal injury: A scoping review

open access: yesKnee Surgery, Sports Traumatology, Arthroscopy, Volume 34, Issue 2, Page 724-751, February 2026.
Abstract Return to performance (RTPe), the final stage of the return to sport (RTS) continuum remains poorly defined in current soccer‐related musculoskeletal (MSK) research, with limited identification and application of physical and/or psychological performance‐based indicators.
Peter Eppinga   +3 more
wiley   +1 more source

UEG Week 2021 Poster Presentations

open access: yes, 2021
United European Gastroenterology Journal, Volume 9, Issue S8, Page 262-907, October 2021.
wiley   +1 more source

PB1821 REAL‐WORLD HEALTHCARE RESOURCE UTILIZATION (HRU) AND COSTS OF DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL) PATIENTS INITIATED ON ANTI‐CANCER THERAPIES IN THE UNITED STATES (US)

open access: yesHemaSphere, Volume 3, Issue S1, Page 834, June 2019., 2019
Background: DLBCL, the most common type of non‐Hodgkin lymphoma in the US, is associated with significant HRU and healthcare costs. In October 2015, DLBCL administrative claims were differentiated from primary mediastinal large B‐cell lymphoma (PMBCL) with the advent of ICD‐10‐CM disease‐specific codes, allowing a more detailed examination of real ...
X. Yang   +8 more
wiley   +1 more source

Restaging Rituals: Methodologies for Dialogue With Migrant Workers and Communities in Agro‐Industrial Localities Under Pressure

open access: yesSociologia Ruralis, Volume 66, Issue 1, January 2026.
ABSTRACT This article examines how agricultural rituals can serve as methodological tools to uncover migrant workers’ voices and facilitate dialogue in agro‐industrial regions under pressure. On the basis of 2 years of ethnographic fieldwork in Haspengouw, Belgium, and Westland, the Netherlands, the research combined participant observation in ...
Carolien Lubberhuizen
wiley   +1 more source

PB1822 HIV‐ASSOCIATED LYMPHOMA: A REPORT OF 40 CASES AT YOPOUGON TEACHING HOSPITAL IN CÔTE D’IVOIRE

open access: yesHemaSphere, Volume 3, Issue S1, Page 834-835, June 2019., 2019
Background: Lymphomas are a heterogeneous group of malignant haemopathies characterized by ganglionic and extra ganglionic infiltration of lymphoid cells. Their occurrence during the HIV infection had a specific clinical, therapeutic and evolutionary particularities.
B. Kouakou   +12 more
wiley   +1 more source

Sharpe Oranı ve Treynor Endeksi Performans Ölçülerine Dayalı Genetik Algoritma Yaklaşımı

open access: yesSüleyman Demirel Üniversitesi Fen-Edebiyat Fakültesi Fen Dergisi, 2021
Yatırımcı her zaman kendisine en yüksek faydayı sağlayacak olan portföyü oluşturmak istemektedir. Bu durum optimize edilmesi gereken portföy problemini ortaya çıkartır.
Azize Zehra Çelenli Başaran
doaj   +1 more source

Long‐term outcomes of endoscopic ultrasound‐guided hepaticogastrostomy in patients with malignant biliary obstruction

open access: yesUnited European Gastroenterology Journal, Volume 12, Issue 8, Page 1044-1055, October 2024.
Hepaticogastrostomy drainage via endoscopic ultrasound (EUS‐HGS) is a newer technique for biliary decompression in cases of endoscopic retrograde cholangiopancreatography (ERCP) failure for malignant biliary obstruction (MBO). EUS‐HGS has shown high technical and clinical success with acceptable risk in short‐term outcomes.
Abdellah Hedjoudje   +7 more
wiley   +1 more source

PB2146 SINGLE AGENT DARATUMUMAB IN VERY ADVANCED RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS: A REAL‐LIFE SINGLE CENTER RETROSPECTIVE STUDY

open access: yesHemaSphere, Volume 3, Issue S1, Page 965-966, June 2019., 2019
Background: Daratumumab is approved as a single agent for the treatment of patients (pts) with relapsed and refractory multiple myeloma (RRMM) who have received at least three prior lines of therapy, including a proteasome inhibitor (PI) and an immunomodulatory agent (IMID), or who are double refractory to a PI and an IMID.
M. Jullien   +16 more
wiley   +1 more source

Home - About - Disclaimer - Privacy